For Sposnorship Packages, please contact
+966 56 650 6264
List of Sponsors
We helps put better health within reach, every day We create high-quality medicines and make them accessible to the people who need them.
Global experts with a local presence, we think creatively and act practically, transforming cutting-edge science into innovative solutions that transform people’s lives, for a healthier world wherever we are.
We develop, manufacture and market a broad range of branded and non-branded generic pharmaceutical products across the US, the Middle East and North Africa (MENA) and Europe. We are also a leading licensing partner in MENA.
Our global operations:
- Headquarters in London, UK.
- Listed on both the London Stock Exchange and the NASDAQ Dubai
- Nearly 30 Manufacturing plants in 11 countries
- 7 R&D centers worldwide
- +50 Countries where we have operations
- +8,000 Talented employees
- Nearly $2bn Worldwide sales (as of 2017)
3 Diverse and distinct business units: Injectables, Generics & Brands
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Headquartered in Riyadh, MEDISERV was established in the year 7-04-1980G corresponding to 21-05-1400H, MEDISERV is a major medical and laboratory equipment and supplies distributor both to the government and private sectors. Over the past 36 years the company has developed a solid business relationship with all leading health care institutions throughout the Kingdom through its Riyadh head office and branches in Jeddah, Khobar & Abha ensuring that our market coverage today is extensive for all medical sales, distribution and service.
Abbott, Carefusion Healthcare Products, Ambu, B.Braun, Pentax, Schiller, Penlon Ltd., Ardo, Immucor, and Hologic are representative of the international manufacturers we mainly represent.
Presently MEDISERV employs around 500 people throughout Saudi Arabia. Of this total, around 50 are engaged in sales and direct customer development activities, and around 70 are engineers who are fully trained to maintain and service medical equipment at our own workshops or the customer's site. This is the nucleus already available to us from which we can easily build up a specific set up to best cater for the marketing, sales and distribution needs of all the product range.
DaVita Inc., a Fortune 500® company, is one of the nation’s largest and most innovative health care communities, leveraging a passion for and commitment to clinical excellence and improving patients' health and quality of life.
As an operating division of DaVita, DaVita Kidney Care focuses on setting worldwide standards for clinical, social and operational practices in kidney care. From raising awareness of kidney diseases to providing industry-leading, no-cost diet- and health-management resources to people diagnosed with it, DaVita Kidney Care continues its pursuit to keep people off dialysis as long as possible—and to improve access to treatment and quality of life for those who do need dialysis.
DaVita Medical Group, provides integrated care management as an operating division of DaVita, focusing on delivering outstanding healthcare across a broad range of services. DaVita Medical Group works with its patients to help them live life to the fullest and strives to lead the transformation of the national healthcare delivery system to ensure quality, accessible and affordable care for all.
Vifor Pharma Group is a global specialty pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348). For more information, please visit www.viforpharma.com
The leading provider of products and services for people with chronic kidney failure
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 3.2 million patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
We care for more than 325,000 patients in our global network of more than 3,800 dialysis clinics. At the same time, we operate 41 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
Our strategy is geared toward sustainable growth. We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.
Algorithm traces its history back to 1961 and was initially established as Charles. E. Frosst & Co. (M.E.) SAL plant.
The company was a subsidiary of Merck & Co. Inc. (MSD) until December 1989 time at which the plant was acquired by the Shareholders of Droguerie De L'Union - distributors of MSD in Lebanon; the name changed to Algorithm SAL with the change of ownership.
Algorithm has since concluded several strategic licensing deals that have strengthened its portfolio and pipeline, hence shaping its future. Algorithm also develops its own line of in-house differentiated generics.
Today, Algorithm is a regional Pharmaceutical Company operating in the MENA region and committed to improving human health and well-being. It is focused on the following therapeutic lines: Cardio-metabolic, Neurology, Urology, Pain & Inflammation, Gastroenterology & Infectiology.
The core values of its Human Resources have shaped its culture:
- Trust and Respect
- Ethics and Integrity
- Responsibility and Accountability
- Quality and Excellence
Algorithm strives to:
- Manufacture and market quality pharmaceutical products
- Provide access to the best treatment options to healthcare professionals and to patients
- Support a rewarding work environment
At Baxter, we believe every person deserves a chance for a healthy life, free from illness and full of possibility. We focus each day on delivering transformative innovations that bring smarter, more personalized care to all of us.
Our Commitment to Providers and Patients
We work at the critical intersection where innovations that save and sustain lives meet the physicians, nurses and pharmacists who make it happen. We are committed to improving outcomes for patients, and helping our partners meet the evolving challenges and opportunities in healthcare around the world. Learn more about our diverse specialties.
Baxter is focused on providing renal patients (Chronic and acute) the best possible life by elevating the standards of care across all therapeutic options, whether that be in-center or home care or ICU. Baxter is committed to addressing the individual needs of patients by supporting greater access to innovative renal care products, therapies, services and support globally.
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
The Novartis Mission and Vision
Our mission is to discover new ways to improve and extend people`s lives.
Our vision is to be a trusted leader in changing the practice of medicine.
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our businesses - Innovative Medicines, Alcon and Sandoz - are supported by functional organizations with global scale. Research and development (R&D) is at the core of our company and central to the Novartis strategy.
Fortune's Most Admired Pharmaceutical Companies 2018
Novartis has been ranked #3 by Fortune magazine as one of the most admired pharmaceutical companies in the world — our 14th consecutive year in the top three.
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) is a Saudi Joint–Stock company with a fully paid-up capital of SR 1,200,000,000 . It was established in 1986 . SPIMACO Addwaeih’s core business is medical and pharmaceutical, which includes development, manufacturing and sales of pharmaceutical products and medical appliances. Moreover, SPIMACO also has ownership in number of joint stock ans limited liabilities companies inside and outside the Kingdom . SPIMACO has developed a strong position in Saudi Arabia and is well positioned to sustain its growth and have a sound platform to serve export markets.
SPIMACO main manufacturing facility – Al–Qassim Pharmaceutical Plant was planned , constructed and equipped up to the highest quality levels. SPIMACO earned a lot of national quality awards and attained major international certifications.
SPIMACO serves successfully several markets locally and internationally and have built superior relations with regulatory bodies and the medical professions at large. The heavy investments in regulatory, marketing, sales and international alliances gave SPIMACO the market capabilities to prosper and overtake a lot of competitors.
An important and distinctive advantage of SPIMACO strategy is its relations with multinational companies. A very flexible, objective and versatile approach let to a multitude of relationships that served the interests of all parties. SPIMACO is a successful joint stock company and it has one of the most actively traded shares in the Saudi stock market.
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
Zemplar is the first selective Vit-D receptor activator that, it affords effective management of SHPT in patients with all stages of CKD ZEMPLAR has been shown to reduce PTH with less impact on P and Ca when compared to calcitriol. ZEMPLAR provides superior reduction of iPTH to target levels with minimal effects on calcium with HD patients compared with Cinacalcet plus low-dose vitamin D therapy
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops, manufactures and markets pharmaceutical drugs in more than 100 countries globally. The company has its own sales forces in 61 countries and employs around 4,800 people worldwide. LEO Pharma is headquartered in Denmark and is wholly owned by the LEO Foundation.
At LEO Pharma, we are dedicated to developing drugs and therapies that deliver unique value to patients and societies all around the world. Adapting quickly to new demands, we supply medicines and solutions to patients suffering from skin infections and diseases such as psoriasis, acne and eczema, as well as conditions that require supportive treatments such as thrombosis, kidney disease and cancer.